Heart disease is among the leading causes of death globally and imposes a significant burden on the health-care system. We know some of the causes of heart disease: smoking, unhealthy diet, obesity, high blood pressure, diabetes and genes.
But there are also a lot of people who die from heart disease who don’t have any of these risk factors. Studies are trying to find out why, and it appears the immune system and inflammation in the body could be to blame.
The most common type of heart disease is coronary artery disease, which affects the blood vessels of the heart. Coronary artery disease is mainly caused by blockages that affect blood flow to the heart muscle, which interrupts the supply of oxygen and other important nutrients.
The most common cause of this blockage is the build-up of fatty molecules called lipids (which largely consist of cholesterol) leading to plaque forming inside the vessels, and swelling (inflammation) within the walls of the blood vessels. This process is called atherosclerosis.
These plaques don’t usually cause any symptoms for the first few decades, until there is significant narrowing of the vessel or there is disruption of the plaque surface (a piece of the plaque breaks off, causing a blood clot) which leads to a heart attack.
How does the immune system affect the heart?
Recent evidence suggests cholesterol crystals in the plaque that builds up in atherosclerosis trigger the release of molecules from the immune system. These molecules cause inflammation and promote blood vessel injury and plaque instability, leading to heart attacks, strokes and death.
Immune cells have receptors that serve as sentry guards. They sense various potentially harmful molecules (such as foreign proteins, cell debris or damaged DNA), then send out molecules (like soldiers) to remove these “threats”. The strength of this response can be heightened as a result of a person’s genes - as is the case in some autoimmune diseases.
Elevated levels of these soldier molecules, “cytokines”, have been linked with coronary artery disease. These cytokines can actually do us harm though, by overstimulating the immune system to try to remove cholesterol crystals in the blood vessel walls. This overstimulation causes inflammation in the layers of the blood vessel wall.
Lowering these cytokines with cholesterol medications (statins) has been shown to reduce the progression of atherosclerosis, as well as reducing the number of heart events, including heart attacks that cause death.
So this means we now have a marker to tell us who will be at higher risk of heart attack and stroke, even if they have healthy lifestyles. Doctors can perform a simple blood test to measure the presence of this inflammation marker (one of which is “C-reactive protein” or CRP), which can tell us who is likely to be at risk.
Heart attack victims are particularly vulnerable in the period just after their attack, because the inflammation in the arteries can lead to more plaque becoming unstable and chipping off. This instability and subsequent plaque rupture is the triggering event that leads to most heart attacks.
Even with optimal medical therapy, the incidence of further adverse events in patients after the initial heart attack is as high as 20%. This is possibly because the current treatment options aren’t targeting these cytokines that cause inflammation well enough.
Statins and aspirin both exert indirect anti-inflammatory effects and are first-line treatment options in patients with coronary artery disease.
Colchicine, the oldest anti-inflammatory drug after aspirin that is still in routine clinical use has been shown in an Australian study to reduce heart attacks in patients with stable coronary artery disease. Colchicine is currently used in the treatment of gout and Familial Mediterranean Fever, both of which are inflammatory disorders. There’s also emerging evidence another drug, Canakinumab, blocks a specific type of cytokine, reducing the risk of follow-up heart attacks.
A recent study published in the British Medical Journal showed an increased risk of heart attacks in patients who were taking non-steroid anti-inflammatory drugs, which are commonly used painkillers. It’s important to note this study is observational and demonstrates an association, with the drugs not proved to be a direct cause of heart attack. It advises caution when prescribing or taking these painkillers, until more definitive studies are carried out.
More research needs to be done to better understand the exact immune processes in heart disease so we can find out exactly what the risks are. Targeting risk factors for atherosclerosis has reduced the death rate, but new therapies are needed to stabilise atherosclerotic plaques and to treat heart blood vessel inflammation to reduce the risk of recurrent heart attacks.
About The Author
Rahul Kurup, Research fellow, Cardiologist, Heart Research Institute
Trusted by generations of cardiologists for the latest, most reliable guidance in the field, Braunwald’s Heart Disease, 11th Edition, remains your #1 source of information on rapidly changing clinical science, clinical and translational research, and evidence-based medicine. This award-winning text has been completely updated, providing a superior multimedia reference for every aspect of this fast-changing field, including new material about almost every topic in cardiology.
- A unique update program by Dr. Braunwald creates a "living textbook" by featuring weekly Hot off the Press, periodic Late-Breaking Clinical Trials (including links to authors’ presentation slides), and monthly Focused Reviews.
- More than a dozen new chapters cover Chronic Lung Disorders and Cardiovascular Disease; Transcatheter Treatment of Congenital Heart Disease; Approach to the Patient with Valvular Heart Disease; Obesity and Cardiometabolic Disease; Environmental Exposures and CVD; Approach to the Patient with Cardiac Arrhythmias; Cardio-oncology, Precision Medicine, and more.
- New information on clinical cardiovascular genetics; MR PET; MR device compatibility; fibrosis; fusion imaging; OCT; IVUS; left atrial appendage exclusion approaches and other topics.
- Many new videos that elucidate coronary, peripheral, valvular, congenital heart diseases and other cardiovascular diseases.
- Expert Consult™ eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, and references from the book on a variety of devices.
- Great product!
Brand: AMERICAN WEST BOOKS
Based on the groundbreaking results of his twenty-year nutritional study, Prevent and Reverse Heart Disease by Dr. Caldwell Esselstyn illustrates that a plant-based, oil-free diet can not only prevent the progression of heart disease but can also reverse its effects. Dr. Esselstyn is an internationally known surgeon, researcher and former clinician at the Cleveland Clinic and a featured expert in the acclaimed documentary Forks Over Knives. Prevent and Reverse Heart Disease has helped thousands across the country, and is the book behind Bill Clinton’s life-changing vegan diet.
The proof lies in the incredible outcomes for patients who have followed Dr. Esselstyn's program, including a number of patients in his original study who had been told by their cardiologists that they had less than a year to live. Within months of starting the program, all Dr. Esselstyn’s patients began to improve dramatically, and twenty years later, they remain free of symptoms.
Complete with more than 150 delicious recipes perfect for a plant-based diet, the national bestseller Prevent and Reverse Heart Disease explains the science behind the simple plan that has drastically changed the lives of heart disease patients forever. It will empower readers and give them the tools to take control of their heart health.
Student-friendly features of the Sixth Edition include a new, full-color design and illustrations; end-of-chapter summaries; updated content, including recent technological advances; and access to an interactive eBook.
- New full-color presentation makes the text more visually appealing.
- Up-to-date medical imaging and color clinical photographs show real-world examples of cardiovascular diseases and related conditions.
- Updated Chapter Summaries reflect consistency in length and format, making study easier.
- Updated Additional Reading references keep readers abreast of the latest literature in the field.
- Winner of two awards of excellence from the American Medical Writers Association, and recommended by medical schools worldwide.
- Complete content with enhanced navigation
- A powerful search tool that pulls results from content in the book, your notes, and even the web
- Cross-linked pages, references, and more for easy navigation
- A highlighting tool for easier reference of key content throughout the text
- Ability to take and share notes with friends and colleagues
- Quick-reference tabbing to save your favorite content for future use